If you want to learn how to trade biotech stocks, you’ll need to start with the basics. Now, if you’re new…

Kyle Dennis · December 30, 2018 at 12:09 PM

If you’re trying to start trading biotech stocks, you’ll need to know when catalyst events. You’ve probably seen biotech stocks…

Kyle Dennis · October 17, 2018 at 3:17 PM

When you’re trading biotech stocks, there’s a lot of research to do. From analyzing biostatistics, catalyst events and drug candidates,…

Kyle Dennis · September 27, 2018 at 1:56 PM

When you’re trading biotech stocks, you need to conduct your own due diligence. Now, there’s a lot to look at….

Kyle Dennis · August 20, 2018 at 4:50 PM

When you’re learning how to trade biotech stocks, you should focus on catalysts. The whole idea here is: traders and…

Kyle Dennis · August 17, 2018 at 5:12 PM

Biotech and pharmaceuticals are attractive industries for new investors to look into, but if you don’t know key starting points…

Kyle Dennis · August 15, 2018 at 12:01 PM

There is one famous saying in the stock market, “Buy low and sell high.” However, it may be difficult to…

Kyle Dennis · June 28, 2018 at 5:14 PM

Trading pharmaceutical and biotech stocks are difficult. But what if you could learn 3 hacks to trade biotech stocks like…

Kyle Dennis · May 21, 2018 at 12:00 PM

I get this question all the time, “How do I trade biotech stocks?” Well, trading biotech stocks is very difficult…

Kyle Dennis · March 8, 2018 at 8:04 AM

The setup: Catalyst Pharmaceuticals (CPRX) has been forecasting a fourth-quarter Phase 3 data release for its drug Firdapse in treatment…

Kyle Dennis · October 31, 2017 at 8:30 AM

The setup: Cempra, Inc. (CEMP) is a clinical-stage pharmaceutical company that develops differentiated anti-infective drugs. It has two lead products…

Kyle Dennis · October 6, 2017 at 8:30 AM

RagingBull · October 6, 2017 at 8:15 AM

Kyle Dennis of BiotechBreakouts.com likes PTC Therapeutics Inc. (PTCT) ahead of an Oct. 24 FDA-driven catalyst that he believes could…

RagingBull · October 2, 2017 at 8:30 AM

Kyle Dennis of BiotechBreakouts.com likes antibiotic company Cempra Inc., which has a Phase 2-3 data readout coming by the end…

RagingBull · September 25, 2017 at 8:25 AM

The setup: MediciNova, Inc. (MNOV) has a Phase 2B trial for MN-166, ibudilast, indicated for progressive multiple sclerosis. The data…

Kyle Dennis · September 22, 2017 at 8:30 AM